Solid dispersions of itraconazole for inhalation with enhanced dissolution, solubility and dispersion properties

International Journal of Pharmaceutics

Volumn 428, Issue 1-2, 2012, Pages 103-113

  Duret, Christophe ^a   Wauthoz, Nathalie ^a   Sebti, Thami ^b   Vanderbist, Francis ^b   Amighi, Karim ^a  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^b Laboratoires SMB SA   (Belgium)

Author keywords

Amorphous; Dry powder for inhalation; Itraconazole; Pulmonary aspergillosis; Solid dispersion; Spray drying

Indexed keywords

ITRACONAZOLE; MANNITOL; TOCOFERSOLAN;

AEROSOL; ARTICLE; DIFFERENTIAL SCANNING CALORIMETRY; DISPERSION; DRUG FORMULATION; DRUG SOLUBILITY; DRY POWDER; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; SPRAY DRYING; X RAY POWDER DIFFRACTION;

ADMINISTRATION, INHALATION; AEROSOLS; ANTIFUNGAL AGENTS; CALORIMETRY, DIFFERENTIAL SCANNING; CHEMISTRY, PHARMACEUTICAL; DRUG COMPOUNDING; EXCIPIENTS; ITRACONAZOLE; MANNITOL; PARTICLE SIZE; POLYETHYLENE GLYCOLS; POWDERS; SOLUBILITY; TRANSITION TEMPERATURE; VITAMIN E; X-RAY DIFFRACTION;

EID: 84859432248     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2012.03.002     Document Type: Article

References (35)

1. G.L. Amidon, H. Lennernas, V.P. Shah, and J.R. Crison A theoretical basis for a biopharmaceutic drug classification - the correlation of in vitro drug product dissolution and in vivo bioavailability Pharm. Res. 12 1995 413 420
2. N. Blagden, M. de Matas, P.T. Gavan, and P. York Crystal engineering of active pharmaceutical ingredients to improve solubility and dissolution rates Adv. Drug. Deliv. Rev. 59 2007 617 630 (Pubitemid 47285407)
3. C.H. Chang, and E.I. Franses Adsorption dynamics of surfactants at the air/water interface - a critical-review of mathematical-models, data, and mechanisms Colloids Surf., A 100 1995 1 45
4. E. Daviskas, S.D. Anderson, A. Jaques, and B. Charlton Inhaled mannitol improves the hydration and surface properties of sputum in patients with cystic fibrosis Chest 137 2010 861 868
5. M. Freiwald, A. Valotis, A. Kirschbaum, M. McClellan, T. Murdter, P. Fritz, G. Friedel, M. Thomas, and P. Hogger Monitoring the initial pulmonary absorption of two different beclomethasone dipropionate aerosols employing a human lung reperfusion model Respir. Res. 2005 6
6. C. Goddeeris, T. Willems, and G. Van den Mooter Formulation of fast disintegrating tablets of ternary solid dispersions consisting of TPGS 1000 and HPMC 2910 or PVPVA 64 to improve the dissolution of the anti-HIV drug UC 781 Eur. J. Pharm. Sci. 34 2008 293 302
7. M.B. Hickey, M.L. Peterson, L.A. Scoppettuolo, S.L. Morrisette, A. Vetter, H. Guzman, J.F. Remenar, Z. Zhang, M.D. Tawa, S. Haley, M.J. Zaworotko, and O. Almarsson Performance comparison of a co-crystal of carbamazepine with marketed product Eur. J. Pharm. Biopharm. 67 2007 112 119 (Pubitemid 46991320)
8. B.J. Hoeben, D.S. Burgess, J.T. McConville, L.K. Najvar, R.L. Talbert, J.I. Peters, N.P. Wiederhold, B.L. Frei, J.R. Graybill, R. Bocanegra, K.A. Overhoff, P. Sinswat, K.P. Johnston, and R.O. Williams In vivo efficacy of aerosolized nanostructured itraconazole formulations for prevention of invasive pulmonary aspergillosis Antimicrob. Agents Chemother. 50 2006 1552 1554
9. R.M. Jones, and N. Neef Interpretation and prediction of inhaled drug particle accumulation in the lung and its associated toxicity Xenobiotica 42 2012 86 93
10. K. Kawakami, C. Sumitani, Y. Yoshihashi, E. Yonemochi, and K. Terada Investigation of the dynamic process during spray-drying to improve aerodynamic performance of inhalation particles Int. J. Pharm. 390 2010 250 259
11. Y. Lian Amorphous pharmaceutical solids: preparation, characterization and stabilization Adv. Drug Deliv. Rev. 48 2001 27 42
12. T. Loftsson, and M.E. Brewster Pharmaceutical applications of cyclodextrins: basic science and product development J. Pharm. Pharmacol. 62 2010 1607 1621
13. J.T. McConville, K.A. Overhoff, P. Sinswat, J.M. Vaughn, B.L. Frei, D.S. Burgess, R.L. Talbert, J.I. Peters, K.P. Johnston, and R.O. Williams Targeted high lung concentrations of itraconazole using nebulized dispersions in a murine model Pharm. Res. 23 2006 901 911 (Pubitemid 43781398)
14. C. Mobley, and G. Hochhaus Methods used to assess pulmonary deposition and absorption of drugs Drug Discov. 6 2001 367 375 (Pubitemid 32208651)
15. O.R. Moss Simulants of lung interstitial fluid Health Phys. 36 1979 447 448 (Pubitemid 9218628)
16. S.B. Murdande, M.J. Pikal, R.M. Shanker, and R.H. Bogner Solubility advantage of amorphous pharmaceuticals, Part 3: is maximum solubility advantage experimentally attainable and sustainable J. Pharm. Sci. 100 2011 4349 4356
17. S. Pham, and T.S. Wiedmann Dissolution of aerosol particles of budesonide in Survanta (TM), a model lung surfactant J. Pharm. Sci. 90 2001 98 104 (Pubitemid 32050481)
18. G. Pilcer, and K. Amighi Formulation strategy and use of excipients in pulmonary drug delivery Int. J. Pharm. 392 2010 1 19
19. Pilcer, G., Wauthoz, N., Amighi, K., 2011. Lactose characteristics and the generation of the aerosol. Adv. Drug Deliv. Rev., in press.
20. J.E. Polli, G.S. Rekhi, L.L. Augsburger, and V.P. Shah Methods to compare dissolution profiles and a rationale for wide dissolution specifications for metoprolol tartrate tablets J. Pharm. Sci. 86 1997 690 700 (Pubitemid 27248819)
21. C.J.H. Porter, N.L. Trevaskis, and W.N. Charman Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs Nat. Rev. Drug Discov. 6 2007 231 248 (Pubitemid 46344627)
22. H. Schulz Mechanisms and factors affecting intrapulmonary particle deposition: implications for efficient inhalation therapies Drug Discov. Today 1 1998 336 344 (Pubitemid 28526962)
23. A.T.M. Serajuddin Solid dispersion of poorly water-soluble drugs: early promises, subsequent problems, and recent breakthroughs J. Pharm. Sci. 88 1999 1058 1066
24. A.R. Shah, and R. Banerjee Effect of d-alpha-tocopheryl polyethylene glycol 1000 succinate (TPGS) on surfactant monolayers Colloids Surf. B: Biointerfaces 85 2011 116 124
25. K. Six, G. Verreck, J. Peeters, K. Binnemans, H. Berghmans, P. Augustijns, R. Kinget, and G. Van den Mooter Investigation of thermal properties of glassy itraconazole: identification of a monotropic mesophase Thermochim. Acta 376 2001 175 181 (Pubitemid 32803453)
26. K. Six, J. Murphy, I. Weuts, D.Q.M. Craig, G. Verreck, J. Peeters, M. Brewster, and G. Van den Mooter Identification of phase separation in solid dispersions of itraconazole and Eudragit (R) E100 using microthermal analysis Pharm. Res. 20 2003 135 138 (Pubitemid 36152929)
27. K. Six, G. Verreck, J. Peeters, M. Brewster, and G. Van den Mooter Increased physical stability and improved dissolution properties of itraconazole, a class II drug, by solid dispersions that combine fast- and slow-dissolving polymers J. Pharm. Sci. 93 2004 124 131 (Pubitemid 38081820)
28. Y.J. Son, and J.T. McConville Development of a standardized dissolution test method for inhaled pharmaceutical formulations Int. J. Pharm. 382 2009 15 22
29. C.L. Tran, D. Buchanan, R.T. Cullen, A. Searl, A.D. Jones, and K. Donaldson Inhalation of poorly soluble particles. II. Influence of particle surface area on inflammation and clearance Inhal. Toxicol. 12 2000 1113 1126
30. B. Van Eerdenbrugh, J. Vermant, J.A. Martens, L. Froyen, J. Van Humbeeck, G. Van den Monter, and P. Augustijns Solubility increases associated with crystalline drug nanoparticles: methodologies and significance Mol. Pharm. 7 2010 1858 1870
31. T. Vasconcelos, B. Sarmento, and P. Costa Solid dispersions as strategy to improve oral bioavailability of poor water soluble drugs Drug Discov. Today 12 2007 1068 1075 (Pubitemid 350186132)
32. N. Wauthoz, P. Deleuze, A. Saumet, C. Duret, R. Kiss, and K. Amighi Temozolomide-based dry powder formulations for lung tumor-related inhalation treatment Pharm. Res. 28 2010 762 775
33. A. Yan, A. Dem Bussche, A.B. Kane, and R.H. Hurt Tocopheryl polyethylene glycol succinate as a safe, antioxidant surfactant for processing carbon nanotubes and fullerenes Carbon 45 2007 2463 2470 (Pubitemid 47588210)
34. W. Yang, K.P. Johnston, and R.O. Williams Comparison of bioavailability of amorphous versus crystalline itraconazole nanoparticles via pulmonary administration in rats Eur. J. Pharm. Biopharm. 75 2010 33 41
35. J. Zhang, L.B. Wu, H.K. Chan, and W. Watanabe Formation, characterization, and fate of inhaled drug nanoparticles Adv. Drug. Deliv. Rev. 63 2011 441 455